Irawati S, Prayudeni S, Rachmawati R, Wita I, Willfert B, Hak E
BMJ Open. 2020; 10(6):e035098.
PMID: 32540888
PMC: 7299032.
DOI: 10.1136/bmjopen-2019-035098.
Balan S, Hassali M, Mak V
World J Pediatr. 2018; 14(6):528-540.
PMID: 30218415
DOI: 10.1007/s12519-018-0186-y.
Murshid M, Mohaidin Z
Pharm Pract (Granada). 2017; 15(2):990.
PMID: 28690701
PMC: 5499356.
DOI: 10.18549/PharmPract.2017.02.990.
Velasco E, Espelage W, Faber M, Noll I, Ziegelmann A, Krause G
Infection. 2011; 39(4):289-97.
PMID: 21717149
DOI: 10.1007/s15010-011-0137-1.
Baysari M, Westbrook J, Braithwaite J, Day R
Drug Saf. 2011; 34(4):289-98.
PMID: 21417501
DOI: 10.2165/11588200-000000000-00000.
Does managed care affect the diffusion of psychotropic medications?.
Domino M
Health Econ. 2011; 21(4):428-43.
PMID: 21384465
PMC: 3138820.
DOI: 10.1002/hec.1723.
Prescribing in family practice: a method of data collection.
Rosser W
Can Fam Physician. 2011; 27:68-73.
PMID: 21289664
PMC: 2305832.
Introducing a new drug into your practice.
Palmer W, Ross D
Can Fam Physician. 2011; 33:2529-33.
PMID: 21263993
PMC: 2218682.
Survey of pharmaceutical promotion in a family medicine training program.
Fogel M
Can Fam Physician. 2011; 35:1603-5.
PMID: 21248863
PMC: 2280159.
Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework.
Tsimtsiou Z, Ashworth M, Jones R
Br J Gen Pract. 2009; 59(563):e191-8.
PMID: 19520017
PMC: 2688068.
DOI: 10.3399/bjgp09X420923.
Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia.
Cutts C, Tett S
Eur J Clin Pharmacol. 2003; 58(11):761-6.
PMID: 12634983
DOI: 10.1007/s00228-002-0551-5.
A qualitative comparative investigation of variation in general practitioners' prescribing patterns.
Jaye C, Tilyard M
Br J Gen Pract. 2002; 52(478):381-6.
PMID: 12014535
PMC: 1314293.
[Factors conditioning prescription in primary care].
Caamano F, Figueiras A, Gestal-Otero J
Aten Primaria. 2001; 27(1):43-8.
PMID: 11218975
PMC: 7681380.
DOI: 10.1016/s0212-6567(01)78772-0.
[Externally induced prescriptions, degree of agreement and ... possibility of change in primary care?].
Barcelo Colomer E, Grau Bartomeu J, Serre Delcor N, Salgado Pineda M, Marti Dillet M, Hidalgo Ortiz M
Aten Primaria. 2000; 26(4):231-8.
PMID: 11100583
PMC: 7681449.
DOI: 10.1016/s0212-6567(00)78652-5.
Effects of perceived patient demand on prescribing anti-infective drugs.
Miller E, MacKeigan L, Rosser W, Marshman J
CMAJ. 1999; 161(2):139-42.
PMID: 10439821
PMC: 1230462.
Drug utilisation studies as tools in health economics.
Sacristan J, Soto J
Pharmacoeconomics. 1994; 5(4):299-312.
PMID: 10147239
DOI: 10.2165/00019053-199405040-00005.
Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.
Bashford J, Norwood J, Chapman S
BMJ. 1998; 317(7156):452-6.
PMID: 9703528
PMC: 28639.
DOI: 10.1136/bmj.317.7156.452.
A reasoned action approach to physicians' utilization of drug information sources.
Gaither C, Bagozzi R, Ascione F, Kirking D
Pharm Res. 1996; 13(9):1291-8.
PMID: 8893264
DOI: 10.1023/a:1016049311673.
The effect of industry-independent drug information on the prescribing of benzodiazepines in general practice.
Berings D, Blondeel L, Habraken H
Eur J Clin Pharmacol. 1994; 46(6):501-5.
PMID: 7995315
DOI: 10.1007/BF00196105.
Drug promotion and the doctor.
OMalley K, OHanrahan M
Br J Clin Pharmacol. 1982; 14(5):661-4.
PMID: 7138744
PMC: 1427489.
DOI: 10.1111/j.1365-2125.1982.tb04952.x.
